Protein Sequencing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Market Overview

The major factors for the growth of the protein sequencing market include the rising focus on target-based drug development, and increasing funding for proteomics research.

The rising funding for proteomic research is expected to boost the protein sequencing market over the forecast period. In the United States, the Office of Cancer Clinical Proteomics Research (OCCPR) supports the development of technologies and reagents that will advance understanding of protein biology in cancer. Furthermore, recently on January 2018, more than USD 18 million in funding awarded to two national platforms in which the University of Victoria plays a key role to improve the diagnosis and treatment of various diseases such as cancer and Alzheimer’s. In addition, one of the market player Biognosys, in July 2017 announced that it has secured USD 5 million funding from new and existing investors in an extended series C round. Thus, rising funding for the proteomic research is expected to propel the overall growth of the Protein Sequencing market over the forecast period.

Scope of the Report

As per the scope of this report, protein sequencing is the process of determining the amino acid sequence of all or part of a protein or peptide. This techniques are helpful in the identification of proteins and characterize their post-translational modifications. The Protein Sequencing market is segmented by products and services, application, end user, and geography.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Protein Engineering Studies is the Segment by Application expected to be Fastest Growing Segment

Protein engineering is the manipulation of the structures of proteins to produce the desired properties or the synthesis of proteins with particular structures. The majority of therapeutic drugs in the current market are bioformulations, such as antibodies, nucleic acid products, and vaccines. The companies are focusing on field in protein engineering for the site-specific conjugation of functional moieties to biopharmaceuticals is the incorporation of unnatural amino acids (uAA). The rapid developments in post-translational engineering and strain development to produce better-defined products, faster approval of biopharmaceuticals can be expected. Furthermore, according to the data published by the Genetics & Protein Engineering Conferences 2018, roughly 3,000 professionals from 60 over universities in the country, currently work on protein engineering. Thus, owing to the rising focus on protein engineering the market is expected to witness high growth.

To understand key trends, Download Sample Report